Navigation Links
OICR funds Fluorinov Pharma Inc. to further develop its novel drug for the treatment of blood cancers
Date:6/7/2012

TORONTO, June 7, 2012 /PRNewswire/ -- The Ontario Institute for Cancer Research (OICR) today announced $1.5 million in funding over three years for the development of a new drug by Toronto-based Fluorinov Pharma, Inc. The drug, called FV-162, is a highly potent, orally-delivered small molecule proteasome inhibitor with significant advantages over drugs currently used to treat multiple myeloma and some forms of Non-Hodgkin's lymphoma.

"Our investment in Fluorinov Pharma Inc. will move FV-162 towards the market by helping it to meet the preclinical requirements of Health Canada and the FDA," said Mr. Frank Stonebanks, Vice-President, Commercialization and Chief Commercial Officer of OICR. "This novel drug is very promising and could improve the quality of life and outcomes of patients with certain blood cancers."

An important target for therapies treating blood cancers such as multiple myeloma is the proteasome, a part of the cell that recycles old proteins. While effective, the current proteasome inhibitor-based treatment is toxic and requires intravenous delivery. Additionally, some cancers develop resistance over time.

FV-162 has the potential to vastly improve the current treatment because it has lower toxicity, can be taken orally and has shown to be effective against drug-resistant cancer cells in the laboratory.  

Fluorinov Pharma Inc. developed FV-162 using a unique medicinal chemistry technology in which fluorine atoms are placed into drug candidates to enhance their pharmacokinetic properties and biological activities. FV-162 works by selectively inhibiting the chymotrypsin-like enzymatic activity of the proteasome.

OICR is supporting Fluorinov Pharma Inc.'s development of FV-162 through its Intellectual Property Development and Commercialization (IPDC) Fund, which was established to bridge the gap in the commercialization process between support from traditional public funding agencies and private investors.
'/>"/>

SOURCE Ontario Institute for Cancer Research (OICR)
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Rapid Fire Marketing Funds Development of Second Generation Vapor Inhaler
2. First sales of DIFICLIR™ by Astellas Pharma Europe triggers 10 Million Euro Milestone Payment to Optimer Pharmaceuticals
3. InnoPharma Inc. Raises $8 Million in Venture Debt
4. Bausch + Lomb Completes the Acquisition of ISTA Pharmaceuticals
5. Nouveau Life Pharmaceuticals (NOUV) to Begin Sales of Azul Instant™
6. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
7. Next Generation Pharmaceutical Manufacturing Summit Pushes the Envelope of Thought-Leadership at its September Summit in London
8. Attack on the Website of the American Pharmacists Association
9. SOCMAs Bulk Pharmaceuticals Task Force Welcomes House Passage of FDA Reform Act
10. Tris Pharma Announces Approval of First-Ever Generic to Delsym® Dextromethorphan Polistirex Extended-Release Suspension
11. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... , Aug. 22, 2014  Cannabis Science, Inc. ... formulation-based drug development and related consulting, is pleased ... international medical cannabis conference taking place at the ... , on October 22, 2014.  The multilingual ... such as researchers, health professionals, and patients, to ...
(Date:8/22/2014)... 2014  WaferGen Bio-systems, Inc. (NASDAQ: WGBS) today announced ... of common stock and warrants at a price of ... prior to deducting underwriting discounts and commissions and offering ... are immediately separable and will be issued separately.  The ... on The NASDAQ Stock Market under the ticker symbol ...
(Date:8/21/2014)... 2014  Vermillion, Inc. (NASDAQ: VRML ), ... women,s health, has appointed Holly B. Bauzon ... Ms. Bauzon has a proven track record in ... laboratory services companies. She has more than 20 years ... she held the position of Director, Lab Services Sales ...
Breaking Medicine Technology:Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 2Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2
... May 3 Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX ) announced ... closes on Thursday, May 13, 2010 .  A conference call and live ... 5:00 p.m. Eastern Time to discuss the results. , ... To participate in the call, please dial 877-303-1298 (for ...
... EATONTOWN, N.J. , May 3 Osteotech, Inc. (Nasdaq: ... products for regenerative healing, announced today that the Company,s first quarter ... before the market opens on Monday, May 10, 2010 . ... webcast on Monday, May 10, 2010 , at 9:00 ...
Cached Medicine Technology:Cumberland Pharmaceuticals To Announce First Quarter 2010 Financial Results on May 13, 2010 2Osteotech Announces First Quarter 2010 Financial Results Release and Conference Call 2
(Date:8/22/2014)... “Dr. Luciana Show – Aging and Falling” is currently ... finding it challenging to stay on top of post-production tasks ... of students, so the editing of the episodes will take ... she recently entered it into the festival circuit. , ... actor/screenwriter Gregory Graham , the aging and falling show ...
(Date:8/22/2014)... the leading pan-European organisation representing medical oncology professionals, ... receiving the Society,s esteemed annual awards. The awards ... and Peter Boyle on the occasion of the ... Carsten Bokemeyer will receive the ESMO Award for ... discovery into real benefit at patient level. 1 ...
(Date:8/22/2014)... Chest pain, breathing difficulties, fainting. Each year approx. 265,000 ... of serious illness. New research from Aarhus University and ... as many as every fourth patient are ... severe symptoms that led to the acute hospitalisation., "Naturally, ... examinations at the hospital disprove that there is a ...
(Date:8/22/2014)... disease can be slowed and some of its ... found in pomegranate. Also, the painful inflammation ... Parkinson,s disease could be reduced, according to the ... of Huddersfield scientist Dr Olumayokun Olajide, who specialises ... Now, a new phase of research can explore ...
(Date:8/22/2014)... cancer Hodgkin lymphoma will be able to better understand ... risk of premature menopause with different treatments. , The ... National Cancer Institute , are based on the experience ... Wales treated for the cancer over a period of ... that women with Hodgkin lymphoma who receive certain types ...
Breaking Medicine News(10 mins):Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 2Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 3Health News:Professor Luciana Lagana Dedicates to Her CSUN Students the “Dr. Luciana Show-Aging and Falling” AOF Festival Nomination (Screening at Krikorian Monrovia Cinema on 08/25) 4Health News:ESMO honors outstanding oncology professionals 2Health News:ESMO honors outstanding oncology professionals 3Health News:Many patients are discharged without a diagnosis 2Health News:Research underway to create pomegranate drug to stem Alzheimer's and Parkinson's 2Health News:Scientists map risk of premature menopause after cancer treatment 2
... to Enable System Turn-On At Grand Opening and ... LodgeNet Healthcare, a division of LodgeNet Interactive ... leading provider of interactive patient television solutions, today ... is now serving patients at the Oklahoma Heart ...
... Continuing Care Retirement Community To Be Built on 59-Acre ... BRIARCLIFF MANOR, N.Y., May 19 ... Care Retirement Community (CCRC), announced today that it has ... State Department of Health. The Certificate of Authority, which ...
... Efficient Registration and Revenue Cycle Management ProcessesMOBILE, Ala., ... announced today that it has agreed to partner ... to an SSI product. SSI,s ClickON(R) PREVENT ( ... will be powered by Boston Software Systems, flagship ...
... MetroHealth Wall of Hope and Chris Evert Children,s Hospital ... CareTech Solutions, Inc. ( www.caretechsolutions.com ), ... provider for hospitals and health systems, has been honored ... the 2009 Aster Award ( www.AsterAwards.com ) ...
... 14 European groups, headed by Prof. Nils Brose of the ... million Euro, on behalf of the European Union, to study ... One of the research teams is headed by Prof. Kobi ... Ethology and has been awarded a grant of 600,000 Euro. ...
... Private Equity Firm Augments Team to Support Continued ... May 19 Water Street Healthcare Partners ... health care industry, announced today that it has expanded its ... The firm has appointed Peter Strothman to principal and ...
Cached Medicine News:Health News:LodgeNet Healthcare Announces Deployment of Interactive Patient Television System in Oklahoma Heart Hospital 2Health News:LodgeNet Healthcare Announces Deployment of Interactive Patient Television System in Oklahoma Heart Hospital 3Health News:The Club at Briarcliff Manor Receives Certificate of Authority from New York 2Health News:The Club at Briarcliff Manor Receives Certificate of Authority from New York 3Health News:SSI Group to Integrate Boston Software Systems' Boston WorkStation Into ClickON PREVENT 2Health News:SSI Group to Integrate Boston Software Systems' Boston WorkStation Into ClickON PREVENT 3Health News:CareTech Receives National Recognition in 2009 Aster Awards for Medical Marketing Excellence 2Health News:CareTech Receives National Recognition in 2009 Aster Awards for Medical Marketing Excellence 3Health News:Water Street Healthcare Partners Expands Team With Senior Investment Professionals 2Health News:Water Street Healthcare Partners Expands Team With Senior Investment Professionals 3
Eberbach's 2800 Series Micro Slide Cabinets provide safe, short-term and long-term, storage of prepared slides which can easily be indexed for retrieval. Cabinets are available in (2) two styles, a U...
Compact storage cabinets for 35 mm slides....
Fisherbrand* Micro Slide Cabinet is made of heavy gauge, reinforced steel....
Slide Sorters for sorting and viewing 5 cm x 5 cm (2 inches x 2 inches) color slides....
Medicine Products: